The approval of Moderna’s Corona vaccine has cleared another hurdle. The European Medicines Agency (EMA) gave the green light.
The European Medicines Agency (EMA) has recommended conditional marketing authorization for U.S. pharmaceutical company Moderna’s Corona vaccine. The EMA made the announcement in Amsterdam on Wednesday. The final decision on the approval must now be made by the EU Commission – which is considered a formality.
The EU can call a total of 160 million doses of Moderna. For Austria, which is always entitled to about 2 percent of the EU quota, this means doses amounting to 3.2 million. In the first quarter, 200,000 doses will be supplied by Moderna. This means that Austria can vaccinate more than 500,000 people in the first quarter with vaccines from Biontech/Pfizer and Moderna. Federal Chancellor Sebastian Kurz also hopes for early approval of the vaccine from Astra Zeneca. Health Minister Rudolf Anschober spoke on Twitter of “good news for the EU and Austria.” The early approval means “tailwind for the vaccination campaign.” Anschober also expects Astra Zeneca’s approval in February.
- Source: heute.at/picture: pixabay.com
This post has already been read 591 times!